TIME – May 13, 2014 – Knowing which prostate cancers will produce aggressive, fast-growing tumors would give doctors the key to choosing the optimal treatment. Until now, that hasn’t been possible, but researchers at Columbia University, New York think they have found the answer. They report in the May journal Cancer Cell that when two known genes linked to prostate cancer are both active, or turned on, the cancer will progress rapidly. Led by Andrea Califano, director of Columbia’s Genome Center, the researchers are working to develop a test that will allow doctors to know whether a man’s prostate cancer has both genes activated.
No comments:
Post a Comment